Vanni, K. M., Berliner, N., Paynter, N. P., Glynn, R. J., MacFadyen, J., Colls, J., . . . Solomon, D. H. (2020). Adverse Effects of Low‐Dose Methotrexate in a Randomized Double‐Blind Placebo‐Controlled Trial: Adjudicated Hematologic and Skin Cancer Outcomes in the Cardiovascular Inflammation Reduction Trial. ACR Open Rheumatol.
Chicago Style CitationVanni, Kathleen M.M., et al. "Adverse Effects of Low‐Dose Methotrexate in a Randomized Double‐Blind Placebo‐Controlled Trial: Adjudicated Hematologic and Skin Cancer Outcomes in the Cardiovascular Inflammation Reduction Trial." ACR Open Rheumatol 2020.
Cita MLAVanni, Kathleen M.M., et al. "Adverse Effects of Low‐Dose Methotrexate in a Randomized Double‐Blind Placebo‐Controlled Trial: Adjudicated Hematologic and Skin Cancer Outcomes in the Cardiovascular Inflammation Reduction Trial." ACR Open Rheumatol 2020.